Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Cypherpunk Technologies Inc (CYPH)
NASDAQFinancialsAsset ManagementSnapshot 2026-11-05
$2.47-13.94%
Close 2026-11-05 · 1-day change
NASDAQFinancialsAsset ManagementSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.42 → 0.42 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CYPH yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Reduce negative cash flow from operations to at least -$3.4M by 2026-Q1 | Cash from operations improved from -$15.5M to -$3.4M in the same period. | Broken | cash flow from operations remains below -$3.4M beyond 2026-Q1 | Cash from operations: $-2.692M FY2026-Q2; GAAP. Published target: >= -3.4 million USD. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 12, 2026-2,692,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, high-risk business rather than a proven durable compounder. The thesis is still in a watch state, and confidence in the evidence is low.
The available valuation signal says CYPH is cheap versus peers, and its valuation measure recently fell. The evidence does not show exactly what earnings or growth the market assumes, so the expectations gap is unclear.
Near term, earnings risk is elevated: recent results have been erratic, and CYPH missed its most recent quarter. Over the multi-year view, operating losses have narrowed, while privacy technology, digital asset treasury activity, and sirexatamab development show progress; however, reported net income also benefited from an unrealized gain on ZEC holdings.
The multi-year thesis hinges on continued improvement in operating income, progress in advancing sirexatamab, and execution of the digital asset strategy. Near-term sector support could weaken if rates fall or financial-sector bellwethers miss or guide lower, while stronger results and guidance from those companies could sustain sector momentum.
For the next 1 to 3 years, CYPH has some operational and development progress, but weak performance, volatile management, and elevated earnings risk leave the thesis uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain Nasdaq listing by resolving closing bid price deficiency |
| A supporting condition in Cypherpunk Technologies Inc's published investment case. The stated target is closing bid price >= $1.00. |
| Recovered |
| stock price remains below $1.00 for 30 consecutive business days |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operating income to at least -$4.8M by 2026-Q1 | A primary condition in Cypherpunk Technologies Inc's published investment case. The stated target is >= -4.8 million USD. | Broken | operating income remains below -$4.8M beyond 2026-Q1 | Operating income: $-4.689M FY2026-Q2; GAAP. Published target: >= -4.8 million USD. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 12, 2026-4,689,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Research and development expenses were $0.2 million for the three months ended June 30, 2026, compared to $10.5 million for the same period in 2025.” “Research and development expenses were $0.2 million for the three months ended March 31, 2026, compared to $12.9 million for the same period in 2025.” Delivery assessment Nov 5, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.09 → $0.42 · observed estimates
$0.01B → $0.14B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-07-25 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-07-26 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-07-27 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-07-28 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-07-29 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-07-30 | $-0.09 | $0 | 1 / 1 |
| 2026-07-31 | $-0.09 | $0 | 1 / 1 |
| 2026-08-01 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-02 | $-0.09 | $0 | 1 / 1 |
| 2026-08-03 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-04 | $-0.09 | $0 | 1 / 1 |
| 2026-08-05 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-06 | $-0.09 | $0 | 1 / 1 |
| 2026-08-07 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-08 | $-0.09 | $0 | 1 / 1 |
| 2026-08-09 | $-0.09 | $0 | 1 / 1 |
| 2026-08-10 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-11 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-12 | $-0.09 | $0 | 1 / 1 |
| 2026-08-13 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-14 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-15 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-16 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-17 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-18 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-19 | $-0.09 | $9,882,000 | 1 / 1 |
| 2026-08-20 | $0.17 | $58,700,000 | 1 / 1 |
| 2026-08-21 | $0.17 | $58,700,000 | 1 / 1 |
| 2026-08-22 | $0.17 | $58,700,000 | 1 / 1 |
| 2026-08-23 | $0.09 | $58,250,000 | 1 / 1 |
| 2026-08-24 | $0.09 | $58,250,000 | 1 / 1 |
| 2026-08-25 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-08-26 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-08-27 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-08-28 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-08-29 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-08-30 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-08-31 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-01 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-02 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-03 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-04 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-05 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-06 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-07 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-08 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-09 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-10 | $0.12 | $68,500,000 | 1 / 1 |
| 2026-09-11 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-12 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-13 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-14 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-15 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-16 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-17 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-18 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-19 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-20 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-21 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-22 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-23 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-24 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-25 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-26 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-27 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-28 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-29 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-09-30 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-01 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-02 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-03 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-04 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-05 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-06 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-07 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-08 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-09 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-10 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-11 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-12 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-13 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-14 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-15 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-16 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-17 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-18 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-19 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-20 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-21 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-22 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-23 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-24 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-25 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-26 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-27 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-28 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-29 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-30 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-10-31 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-11-01 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-11-02 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-11-03 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-11-04 | $0.42 | $144,750,000 | 1 / 1 |
| 2026-11-05 | $0.42 | $144,750,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.